Literature DB >> 12360142

Prescribing practice for antibiotic prophylaxis for cesarean section in a teaching hospital in Brazil.

Isabela Heineck1, Maria B C Ferreira, Eloir Paulo Schenkel.   

Abstract

BACKGROUND: The contribution of antibiotic prophylaxis to reduce surgical wound infection and endometritis after cesarean section is well-known. Despite the knowledge about the effectiveness of antibiotic prophylaxis with this procedure, the administrative regimens are often inappropriate.
METHODS: The use of antibiotic prophylaxis in cesarean section was evaluated in a reference school hospital. Data were collected from medical records, and they correspond to the 9-month observation during 1995 and 1996.
RESULTS: The cesarean section rate was 26.4% in this period. The total procedures observed was 587. Antibiotic prophylaxis was prescribed in 358 procedures (61%). Cephalothin was the most prescribed drug (98.6%), with a regimen of 2 g intravenously after clamping of the umbilical cord and 2 more doses of 1g every 6 hours. Antibiotic prophylaxis was indicated more frequently in patients younger than 30 years and in those with rupture of membranes for more than 6 hours; such differences were significant (P <.05 and P <.00001, respectively).
CONCLUSION: The prescribers met the hospital guidelines for antibiotic prophylaxis in only 37.1% of the cesarean sections performed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12360142     DOI: 10.1067/mic.2002.123347

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  2 in total

1.  Surgeons' adherence to guidelines for surgical antimicrobial prophylaxis - a review.

Authors:  Ru Shing Ng; Chee Ping Chong
Journal:  Australas Med J       Date:  2012-10-31

2.  Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function.

Authors:  Noel T Mueller; Hakdong Shin; Aline Pizoni; Isabel C Werlang; Ursula Matte; Marcelo Z Goldani; Helena A S Goldani; Maria G Dominguez-Bello
Journal:  Genes (Basel)       Date:  2017-12-04       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.